Kronos Bio
KRON
KRON was delisted on the 20th of June, 2025.
71 hedge funds and large institutions have $1.05B invested in Kronos Bio in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 7 closing their positions.
3.38% more ownership
Funds ownership: 60.89% → 64.27% (+3.4%)
4% more capital invested
Capital invested by funds: $1.01B → $1.05B (+$43.8M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more call options, than puts
Call options by funds: $2K | Put options by funds: $2K
1% less funds holding
Funds holding: 72 → 71 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$58.2M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$11.5M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$6.95M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$4.44M |
| 5 |
BlackRock
New York
|
+$3.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$3.88M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.99M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.46M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.04M |
KRON Hedge Fund Activity: Q1 2021 in Review
71 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q1 2021, worth a combined $1.05B — up 4.4% from $1.01B a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of KRON and 6 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 18 added.
The largest buyer was Capital World Investors, opening a new position worth an estimated $58.2M. The largest seller was Fidelity Investments, cutting an estimated $17.5M.
- 71 institutional investors held Kronos Bio (KRON) as of Q1 2021, down from 72 in Q4 2020.
- Funds reported $1.05B of Kronos Bio stock for Q1 2021, up 4.4% quarter-over-quarter.
- 6 funds opened new Kronos Bio positions in Q1 2021 and 7 closed out, a net change of -1 holder.
- The largest Kronos Bio buyer in Q1 2021 was Capital World Investors, an estimated $58.2M added.
- The largest Kronos Bio seller in Q1 2021 was Fidelity Investments, an estimated $17.5M sold.
Based on aggregated 13F filings for Q1 2021.